Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis. [electronic resource]
- European journal of neurology Sep 2012
- 1251-5 p. digital
Publication Type: Journal Article
1468-1331
10.1111/j.1468-1331.2012.03743.x doi
Aged Aged, 80 and over Brain Ischemia--complications Cerebral Hemorrhage--chemically induced Cohort Studies Female Fibrinolytic Agents--adverse effects Humans Male Middle Aged Risk Factors Stroke--drug therapy Thrombolytic Therapy--adverse effects Time Factors Tissue Plasminogen Activator--adverse effects Treatment Outcome